138 related articles for article (PubMed ID: 30694002)
1. Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy.
Hayashi Y; Osawa K; Nakakaji R; Minamiyama S; Ohashi N; Ohya T; Iida M; Iwai T; Ozawa T; Oguri S; Koizumi T; Hirota M; Kioi M; Hata M; Mitsudo K
Head Neck; 2019 Jun; 41(6):1777-1784. PubMed ID: 30694002
[TBL] [Abstract][Full Text] [Related]
2. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
3. Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial.
Hayashi Y; Minamiyama S; Ohya T; Iida M; Iwai T; Koizumi T; Oguri S; Hirota M; Kioi M; Hata M; Taguri M; Mitsudo K
Medicina (Kaunas); 2018 Jul; 54(4):. PubMed ID: 30344283
[No Abstract] [Full Text] [Related]
4. Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma.
Mukai Y; Hata M; Mitsudo K; Koike I; Koizumi T; Oguri S; Kioi M; Omura M; Tohnai I; Inoue T
Strahlenther Onkol; 2014 Feb; 190(2):181-5. PubMed ID: 24264464
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old.
Hayashi Y; Mitsudo K; Sakuma K; Iida M; Iwai T; Nakashima H; Okamoto Y; Koizumi T; Oguri S; Hirota M; Kioi M; Koike I; Hata M; Tohnai I
Radiat Oncol; 2017 Jul; 12(1):112. PubMed ID: 28673362
[TBL] [Abstract][Full Text] [Related]
6. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
7. Combined intra-arterial infusion and systemic chemoradiotherapy for stage IV squamous cell carcinoma of the mandibular gingiva.
Nakasato T; Izumisawa M; Akahane A; Kikuchi K; Ehara S; Shoji S; Kogi S; Mizuki H; Sugiyama Y
Jpn J Radiol; 2012 Nov; 30(9):752-61. PubMed ID: 22936237
[TBL] [Abstract][Full Text] [Related]
8. Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
Hayashi Y; Nakamura T; Mitsudo K; Yamaguchi H; Ono T; Azami Y; Takayama K; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Fuwa N; Tohnai I
Head Neck; 2016 Aug; 38(8):1145-51. PubMed ID: 27018982
[TBL] [Abstract][Full Text] [Related]
9. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
[TBL] [Abstract][Full Text] [Related]
10. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
[TBL] [Abstract][Full Text] [Related]
11. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 cases.
Mitsudo K; Hayashi Y; Minamiyama S; Ohashi N; Iida M; Iwai T; Oguri S; Koizumi T; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
Oral Oncol; 2018 Apr; 79():71-77. PubMed ID: 29598953
[TBL] [Abstract][Full Text] [Related]
13. T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer.
Wakisaka N; Hirai N; Kondo S; Aga M; Nakanishi Y; Tsuji A; Endo K; Murono S; Yoshizaki T
Acta Otolaryngol; 2016 Aug; 136(8):834-40. PubMed ID: 27007816
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma.
Heianna J; Makino W; Hirakawa H; Yamashita Y; Tomita H; Murayama S
Int J Oral Maxillofac Surg; 2022 Sep; 51(9):1123-1130. PubMed ID: 34955352
[TBL] [Abstract][Full Text] [Related]
16. Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
Kobayashi W; Teh BG; Sakaki H; Sato H; Kimura H; Kakehata S; Nagahata M
Oral Oncol; 2010 Dec; 46(12):860-3. PubMed ID: 21050802
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
19. A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence.
Liu Q; Xia Y; Chen Y; Zhang J; Deng J; Zhao K
Radiat Oncol; 2020 Apr; 15(1):75. PubMed ID: 32268925
[TBL] [Abstract][Full Text] [Related]
20. Superselective intra-arterial chemotherapy with concurrent radiotherapy for advanced parotid squamous cell carcinoma: a case report.
Kashiwagi N; Fujii T; Nishiyama K; Nakanishi K; Tomiyama N; Yagyu Y; Tsurusaki M; Kitano M; Murakami T
Jpn J Clin Oncol; 2015 Apr; 45(4):378-80. PubMed ID: 25657260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
